By Michele Maatouk
Date: Tuesday 12 Mar 2024
(Sharecast News) - RBC Capital Markets upped its price target on Rentokil on Tuesday to 590p from 575p and maintained its 'outperform' rating. or login to read the full story
The bank said full-year results were slightly ahead, its forecasts for 24/25 are unchanged and management has outlined a "credible plan" to reinvigorate organic growth in North America.
Email this article to a friend
or share it with one of these popular networks:
You are here: news